Lumos Pharma Inc (NAS:LUMO)
$ 4.38 0.08 (1.86%) Market Cap: 37.88 Mil Enterprise Value: 23.84 Mil PE Ratio: 0 PB Ratio: 7.68 GF Score: 48/100

Q4 2023 Lumos Pharma Inc Earnings Call Transcript

Mar 07, 2024 / 09:30PM GMT
Release Date Price: $3.03 (+0.66%)
Operator

Good afternoon, and welcome to Lumos Pharma 2023 fourth quarter and year end conference call. Currently, all participants are in a listen-only mode. Later we will conduct a question and answer session and instructions will follow at that time. As a reminder, this conference call is being recorded. I will now turn the call over to Lisa Miller, Vice President of Investor Relations. Please go ahead.

Lisa Miller
Lumos Pharma Inc - Senior Director of IR

Thank you, operator. Before we proceed with this call, I'd like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports filed with the SEC. Forward-looking statements made during this call speak only as of the date hereof, and the Company undertakes no obligation to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot